These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22260941)

  • 21. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.
    James CA; Bhonsale A; Tichnell C; Murray B; Russell SD; Tandri H; Tedford RJ; Judge DP; Calkins H
    J Am Coll Cardiol; 2013 Oct; 62(14):1290-1297. PubMed ID: 23871885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Orgeron GM; Te Riele A; Tichnell C; Wang W; Murray B; Bhonsale A; Judge DP; Kamel IR; Zimmerman SL; Tandri H; Calkins H; James CA
    Circ Arrhythm Electrophysiol; 2018 Feb; 11(2):e005593. PubMed ID: 29453325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma testosterone and arrhythmic events in male patients with arrhythmogenic right ventricular cardiomyopathy.
    Ren J; Chen L; Zhang N; Chen X; Zhao Q; Chen K; Li X; Ruschitzka F; Duru F; Song J
    ESC Heart Fail; 2020 Aug; 7(4):1547-1559. PubMed ID: 32469163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe.
    Carrick RT; De Marco C; Gasperetti A; Bosman LP; Gourraud JB; Trancuccio A; Mazzanti A; Murray B; Pendleton C; Tichnell C; Tandri H; Zeppenfeld K; Wilde AAM; Davies B; Seifer C; Roberts JD; Healey JS; MacIntyre C; Alqarawi W; Tadros R; Cutler MJ; Targetti M; Calò L; Vitali F; Bertini M; Compagnucci P; Casella M; Dello Russo A; Cappelletto C; De Luca A; Stolfo D; Duru F; Jensen HK; Svensson A; Dahlberg P; Hasselberg NE; Di Marco A; Jordà P; Arbelo E; Moreno Weidmann Z; Borowiec K; Delinière A; Biernacka EK; van Tintelen JP; Platonov PG; Olivotto I; Saguner AM; Haugaa KH; Cox M; Tondo C; Merlo M; Krahn AD; Te Riele ASJM; Wu KC; Calkins H; James CA; Cadrin-Tourigny J
    Eur Heart J; 2024 Feb; 45(7):538-548. PubMed ID: 38195003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of QRS fragmentation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Peters S; Truemmel M; Koehler B
    J Cardiovasc Med (Hagerstown); 2012 May; 13(5):295-8. PubMed ID: 22450866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk stratification for ventricular arrhythmias and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: an update.
    Cadrin-Tourigny J; Bosman LP; Tadros R; Talajic M; Rivard L; James CA; Khairy P
    Expert Rev Cardiovasc Ther; 2019 Sep; 17(9):645-651. PubMed ID: 31422711
    [No Abstract]   [Full Text] [Related]  

  • 28. Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Saguner AM; Vecchiati A; Baldinger SH; Rüeger S; Medeiros-Domingo A; Mueller-Burri AS; Haegeli LM; Biaggi P; Manka R; Lüscher TF; Fontaine G; Delacrétaz E; Jenni R; Held L; Brunckhorst C; Duru F; Tanner FC
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):230-9. PubMed ID: 24515411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update.
    Azaouagh A; Churzidse S; Konorza T; Erbel R
    Clin Res Cardiol; 2011 May; 100(5):383-94. PubMed ID: 21360243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Cadrin-Tourigny J; Bosman LP; Nozza A; Wang W; Tadros R; Bhonsale A; Bourfiss M; Fortier A; Lie ØH; Saguner AM; Svensson A; Andorin A; Tichnell C; Murray B; Zeppenfeld K; van den Berg MP; Asselbergs FW; Wilde AAM; Krahn AD; Talajic M; Rivard L; Chelko S; Zimmerman SL; Kamel IR; Crosson JE; Judge DP; Yap SC; van der Heijden JF; Tandri H; Jongbloed JDH; Guertin MC; van Tintelen JP; Platonov PG; Duru F; Haugaa KH; Khairy P; Hauer RNW; Calkins H; Te Riele ASJM; James CA
    Eur Heart J; 2019 Jun; 40(23):1850-1858. PubMed ID: 30915475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Collaboration.
    Cadrin-Tourigny J; Bosman LP; Wang W; Tadros R; Bhonsale A; Bourfiss M; Lie ØH; Saguner AM; Svensson A; Andorin A; Tichnell C; Murray B; Zeppenfeld K; van den Berg MP; Asselbergs FW; Wilde AAM; Krahn AD; Talajic M; Rivard L; Chelko S; Zimmerman SL; Kamel IR; Crosson JE; Judge DP; Yap SC; Van der Heijden JF; Tandri H; Jongbloed JDH; van Tintelen JP; Platonov PG; Duru F; Haugaa KH; Khairy P; Hauer RNW; Calkins H; Te Riele ASJM; James CA
    Circ Arrhythm Electrophysiol; 2021 Jan; 14(1):e008509. PubMed ID: 33296238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.
    Zorzi A; Rigato I; Bauce B; Pilichou K; Basso C; Thiene G; Iliceto S; Corrado D
    Curr Cardiol Rep; 2016 Jun; 18(6):57. PubMed ID: 27147509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrical Storm in ICD Recipients with Arrhythmogenic Right Ventricular Cardiomyopathy.
    Yin K; Ding L; Hua W; Zhang S
    Pacing Clin Electrophysiol; 2017 Jun; 40(6):683-692. PubMed ID: 28261825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study.
    Gasperetti A; Carrick RT; Costa S; Compagnucci P; Bosman LP; Chivulescu M; Tichnell C; Murray B; Tandri H; Tadros R; Rivard L; van den Berg MP; Zeppenfeld K; Wilde AAM; Pompilio G; Carbucicchio C; Dello Russo A; Casella M; Svensson A; Brunckhorst CB; van Tintelen JP; Platonov PG; Haugaa KH; Duru F; Te Riele ASJM; Khairy P; Tondo C; Calkins H; James CA; Saguner AM; Cadrin-Tourigny J
    Circulation; 2022 Nov; 146(19):1434-1443. PubMed ID: 36205131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Characteristics and Follow-Up of Pediatric-Onset Arrhythmogenic Right Ventricular Cardiomyopathy.
    Roudijk RW; Verheul L; Bosman LP; Bourfiss M; Breur JMPJ; Slieker MG; Blank AC; Dooijes D; van der Heijden JF; van den Heuvel F; Clur SA; Udink Ten Cate FEA; van den Berg MP; Wilde AAM; Asselbergs FW; Peter van Tintelen J; Te Riele ASJM
    JACC Clin Electrophysiol; 2022 Mar; 8(3):306-318. PubMed ID: 35331425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy.
    Protonotarios A; Anastasakis A; Panagiotakos DB; Antoniades L; Syrris P; Vouliotis A; Stefanadis C; Tsatsopoulou A; McKenna WJ; Protonotarios N
    Europace; 2016 Apr; 18(4):610-6. PubMed ID: 25825460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Cadrin-Tourigny J; Bosman LP; Nozza A; Wang W; Tadros R; Bhonsale A; Bourfiss M; Fortier A; Lie ØH; Saguner AM; Svensson A; Andorin A; Tichnell C; Murray B; Zeppenfeld K; van den Berg MP; Asselbergs FW; Wilde AAM; Krahn AD; Talajic M; Rivard L; Chelko S; Zimmerman SL; Kamel IR; Crosson JE; Judge DP; Yap SC; van der Heijden JF; Tandri H; Jongbloed JDH; Guertin MC; van Tintelen JP; Platonov PG; Duru F; Haugaa KH; Khairy P; Hauer RNW; Calkins H; Te Riele ASJM; James CA
    Eur Heart J; 2022 Aug; 43(32):e1-e9. PubMed ID: 35441664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk score for the exclusion of arrhythmic events in arrhythmogenic right ventricular cardiomyopathy at first presentation.
    Vischer AS; Castelletti S; Syrris P; Bastiaenen R; Miles C; Akdis D; Denhaerynck K; Jacoby D; Saguner AM; Krahn AD; Behr ER; McKenna WJ; Pantazis A
    Int J Cardiol; 2019 Sep; 290():100-105. PubMed ID: 31104822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Corrado D; Leoni L; Link MS; Della Bella P; Gaita F; Curnis A; Salerno JU; Igidbashian D; Raviele A; Disertori M; Zanotto G; Verlato R; Vergara G; Delise P; Turrini P; Basso C; Naccarella F; Maddalena F; Estes NA; Buja G; Thiene G
    Circulation; 2003 Dec; 108(25):3084-91. PubMed ID: 14638546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.
    Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Sędkowska A; Cebula S; Musialik-Łydka A; Kalarus Z
    Kardiol Pol; 2012; 70(5):447-55. PubMed ID: 22623232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.